Specialties & Rare Disease
Execution
of Kelaniya
Est. Since
2009
Years of Experience
Pivotal Projects
Volunteers
Investigators
Audits with no Critical Finding
Eminent International Advisory Panel
PROFESSOR DAVID LALLOO
Director Liverpool School of Tropical Medicine and Professor of Tropical Medicine
PROFESSOR JANE ARMITAGE
Professor of Clinical Trials and Epidemiology and Honorary Consultant in Public Health Medicine in the Nuffield Department of Population Health (NDPH) at the University of Oxford
PROFESSOR ANUSHKA PATEL
Professor of Medicine, UNSW Sydney and a cardiologist at Royal Prince Alfred Hospital in Sydney, Australia
Hands on Leadership
Samantha Ranatunga
CEO/Director
Dr. Namal Wijesinghe
Consultant/ Head of Clinical Operations
Chanaka Fernando
General Manager – Finance & Administration
Anuradha Dahanayaka
Senior Manager – Clinical Operations
Thanush Jeevarajah
Senior Manager – Business Development & Regulatory
Ingrid de Silva
Manager – Administration
Shalomi Weerawardena
Manager – Compliance & Quality Assurance
Isuru Edirisinghe
Manager – Human Resources
Rajeewa Perera
Manager – Facilities Management
Upul Ratnayaka
Manager – Information Technology
View More
Therapeutic Expertise
View More
Rare Diseases
As per WHO definition a rare disease affects 1 in 2000 or fewer. There are more than 7000 rare diseases identified and most of them are linked to genetic disorders. In Sri Lanka, it is estimated that more than 2 million people live with rare diseases.
June 13, 2022
Rare Diseases Bulletin V 1.0 I 1.0
“Hope for Cure” is a quarterly bulletin focusing on rare diseases in Sri Lanka. RemediumOne as a clinical research organisation hopes to bring Sri Lankan expertes who treats orphan diseases in Sri Lanka and the […]
Read More
February 5, 2022
Acromegaly
The prevalence of acromegaly in Sri Lanka is estimated 5 in 100,000 population [Population of Sri Lanka 23 million]. Majority (90%) of the patients have facial and acral changes at the time of diagnosis. 80% […]
Read More
February 4, 2022
T1DM
Accurate incidence and prevalence data is not available in Sri Lanka. Clinical evidence and experience based unverified estimates shows prevalence of T1DM is between 1-2％. Most T1DM patients are catered by family. School system is […]
Read MoreAudits & Updates
February 5, 2022
FDA Readiness Programme
RemediumOne organised a FDA Readiness Programme for the Investigators whom we are working with. Madline Ducatte from UK conducted the training. Madline has extensive and global experience in facing FDA audits.
Read More
February 4, 2022
First Sri Lankan ACRP (Association for Clinical Research Professionals, USA) certified CRA from RemediumOne
First Sri Lankan ACRP (Association for Clinical Research Professionals, USA) certified CRA from RemediumOne RemediumOne is proud to announce that the country’s first ACRP (Association of Clinical Research Professionals, USA) certified CRA is from RemediumOne. […]
Read More
February 3, 2022
Virtual Audit at RemediumOne
RemediumOne faced an audit carried out by the sponsor for one of its more complex and pivotal studies. It was the first experience for the company with a virtual audit carried out through an online […]
Read More
Investigators & Site Network
Investigators
August 3, 2022
Another donation series at National Institute of Nephrology Dialysis and Transplant Unit at Maligawatta
In this critical situation our hospitals have been affected in different aspects. We thought to donate Bedsheets, Adult pampers and aluminum containers to improve patient facility at National Institute of Nephrology Dialysis and Transplant Unit […]
Read More
July 1, 2022
Donated Glucose Strips worth Rs.200,000 for the ward patients at the Institute of Cardiology, National Hospital of Sri Lanka
It’s with great pleasure of initiating donation to the Institute of Cardiology, National Hospital of Sri Lanka to help uplift the quality of medical services & ease off the distress of medicine shortage during these […]
Read More
June 15, 2022
Dr. Chula Herath, Consultant Nephrologist at Sri Jayawardenepura General Hospital has contributed immensely to nephro clinical trials in Sri Lanka.
Dr. Chula Herath, Consultant Nephrologist at Sri Jayawardenepura General Hospital has contributed immensely to nephro clinical trials in Sri Lanka. RemediumOne is privileged to work with him in number of trials over the 12 years. […]
Read MoreSite Network
Employee Engagement
June 17, 2022
Leadership Training at Belihuloya
Provided leadership training for our staff at Belihuloya with Wild Drift team. Had a productive two days and refreshed our mind and soul through the training.
Read More
June 15, 2022
Reaching Above and Beyond – The first staff meeting of the year 2022
After 8 months Remedians gathered together in April 2022 to review the organisational progress and to discuss the future prospects. It was a thoughtful and successful event with fun filled evening. Glimpse of staff gathering […]
Read More
International Clinical Trials Day 2022
As we celebrate International Clinical Trials day on 20th May, we would like to emphasize on the contribution you make towards the science and thank all of you for your effort. Let’s be proud Remedians […]
Read MorePublications
View Publication
July 29, 2022
Effects of a Lifestyle Intervention to Prevent Deterioration in Glycemic Status Among South AsianWomen With Recent Gestational Diabetes
View Publication
July 25, 2022
Desidustat in Anemia due to Non- Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-ND)
View Publication
July 18, 2022
Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003)
View Publication
July 12, 2022
Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination
View Publication
February 7, 2022
Polypills for the prevention of cardiovascular disease: a framework for wider use
View Publication
February 6, 2022
Effcay of a Tetravalent Dengue Vaccine in Healthy Children & Adolescents
View Publication